A Clinicopathology and Simplified Molecular Marker-Based Risk Stratification Model for Predicting 3-Year Recurrence in Endometrial Cancer.

Clin Med Insights Oncol · 2026 · PMC12957589 · PMID 41788226

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

borderline significanceP = .052so close (0.05 < p ≤ 0.1)

This superiority persisted in the test cohort (n = 40), where the PM-TERR maintained strong statistical significance (HR = 6.20, 95% CI: 1.85-20.81, P = .003), while ESMO showed only borderline significance (HR = 4.50, 95% CI: 0.98-20.58, P = .052).

also in 4,324 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.